Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARCTIC trial
2008-003325-17Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel and aspirin in coronary arteriosclerosis (4 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Primary composite endpoint and Individual cardiovascular events. Started Aug 2008; status: active.
02
Drugs
clopidogrelaspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2008-003325-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003325-17.